About this Journal Submit a Manuscript Table of Contents
Stroke Research and Treatment
Volume 2013 (2013), Article ID 641943, 17 pages
http://dx.doi.org/10.1155/2013/641943
Research Article

Poststroke Hip Fracture: Prevalence, Clinical Characteristics, Mineral-Bone Metabolism, Outcomes, and Gaps in Prevention

1Department of Geriatric Medicine, The Canberra Hospital, P.O. Box 11, Canberra, Woden, ACT 2606, Australia
2Australian National University Medical School, P.O. Box 11, Canberra, Woden, ACT 2606, Australia
3Department of Orthopaedic Surgery, The Canberra Hospital, P.O. Box 11, Canberra, Woden, ACT 2606, Australia

Received 6 June 2013; Revised 6 August 2013; Accepted 20 August 2013

Academic Editor: David S. Liebeskind

Copyright © 2013 Alexander Fisher et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Ashburn, D. Hyndman, R. Pickering, L. Yardley, and S. Harris, “Predicting people with stroke at risk of falls,” Age and Ageing, vol. 37, no. 3, pp. 270–276, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Jorgensen, T. Engstad, and B. K. Jacobsen, “Higher incidence of falls in long-term stroke survivors than in population controls: depressive symptoms predict falls after stroke,” Stroke, vol. 33, no. 2, pp. 542–547, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Kerse, V. Parag, V. L. Feigin et al., “Falls after stroke: results from the auckland regional community stroke (ARCOS) study, 2002 to 2003,” Stroke, vol. 39, no. 6, pp. 1890–1893, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Ramnemark, M. Nilsson, B. Borssén, and Y. Gustafson, “Stroke, a major and increasing risk factor for femoral neck fracture,” Stroke, vol. 31, no. 7, pp. 1572–1577, 2000. View at Scopus
  5. V. Weerdesteyn, M. De Niet, H. J. R. Van Duijnhoven, and A. C. H. Geurts, “Falls in individuals with stroke,” Journal of Rehabilitation Research and Development, vol. 45, no. 8, pp. 1195–1214, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. C. English, H. McLennan, K. Thoirs, A. Coates, and J. Bernhardt, “Loss of skeletal muscle mass after stroke: a systematic review,” International Journal of Stroke, vol. 5, no. 5, pp. 395–402, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Y. Pang, M. C. Ashe, and J. J. Eng, “Muscle weakness, spasticity and disuse contribute to demineralization and geometric changes in the radius following chronic stroke,” Osteoporosis International, vol. 18, no. 9, pp. 1243–1252, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. R. C. Hamdy, S. W. Moore, V. A. Cancellaro, and L. M. Harvill, “Long-term effects of strokes on bone mass,” American Journal of Physical Medicine and Rehabilitation, vol. 74, no. 5, pp. 351–356, 1995. View at Scopus
  9. L. Jørgensen, T. Engstad, and B. K. Jacobsen, “Bone mineral density in acute stroke patients: low bone mineral density may predict first stroke in women,” Stroke, vol. 32, no. 1, pp. 47–51, 2001. View at Scopus
  10. L. Jørgensen and B. K. Jacobsen, “Functional status of the paretic arm affects the loss of bone mineral in the proximal humerus after stroke: a 1-Year prospective Study,” Calcified Tissue International, vol. 68, no. 1, pp. 11–15, 2001. View at Scopus
  11. L. Jorgensen and B. K. Jacobsen, “Changes in muscle mass, fat mass, and bone mineral content in the legs after stroke: a 1 year prospective Study,” Bone, vol. 28, no. 6, pp. 655–659, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Liu, T. Tsuji, Y. Higuchi, K. Domen, K. Tsujiuchi, and N. Chino, “Osteoporosis in hemiplegic stroke patients as studied with dual-energy X-ray absorptiometry,” Archives of Physical Medicine and Rehabilitation, vol. 80, no. 10, pp. 1219–1226, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Ramnemark, L. Nyberg, R. Lorentzon, U. Englund, and Y. Gustafson, “Progressive hemiosteoporosis on the paretic side and increased bone mineral density in the nonparetic arm the first year after severe stroke,” Osteoporosis International, vol. 9, no. 3, pp. 269–275, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Ramnemark, L. Nyberg, R. Lorentzon, T. Olsson, and Y. Gustafson, “Hemiosteoporosis after severe stroke, independent of changes in body composition and weight,” Stroke, vol. 30, no. 4, pp. 755–760, 1999. View at Scopus
  15. Y. Sato, Y. Fujimatsu, Y. Honda, H. Kunoh, M. Kikuyama, and K. Oizumi, “Accelerated bone remodeling in patients with poststroke hemiplegia,” Journal of Stroke and Cerebrovascular Diseases, vol. 7, no. 1, pp. 58–62, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Sato, H. Kuno, M. Kaji, Y. Ohshima, T. Asoh, and K. Oizumi, “Increased bone resorption during the first year after stroke,” Stroke, vol. 29, no. 7, pp. 1373–1377, 1998. View at Scopus
  17. Y. Sato, H. Kuno, M. Kaji, K. Etoh, and K. Oizumi, “Influence of immobilization upon calcium metabolism in the week following hemiplegic stroke,” Journal of the Neurological Sciences, vol. 175, no. 2, pp. 135–139, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. G. S. Beaupre and H. L. Lew, “Bone-density changes after stroke,” American Journal of Physical Medicine and Rehabilitation, vol. 85, no. 5, pp. 464–472, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Carda, C. Cisari, M. Invernizzi, and M. Bevilacqua, “Osteoporosis after stroke: a review of the causes and potential treatments,” Cerebrovascular Diseases, vol. 28, no. 2, pp. 191–200, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. O. Lazoura, N. Groumas, E. Antoniadou et al., “Bone mineral density alterations in upper and lower extremities 12 months after stroke measured by peripheral quantitative computed tomography and DXA,” Journal of Clinical Densitometry, vol. 11, no. 4, pp. 511–517, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Levendoglu, H. Ugurlu, M. Gurbilek, et al., “Increased bone resorption in the proximal femur in patients with hemiplegia,” American Journal of Physical Medicine & Rehabilitation, vol. 83, no. 11, pp. 835–841, 2004.
  22. J. Marsden, L. M. Gibson, C. E. Lightbody, A. K. Sharma, M. Siddiqi, and C. Watkins, “Can early onset bone loss be effectively managed in post-stroke patients? An integrative review of the evidence,” Age and Ageing, vol. 37, no. 2, pp. 142–150, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. P. K. Myint, K. E. S. Poole, and E. A. Warburton, “Hip fractures after stroke and their prevention,” QJM, vol. 100, no. 9, pp. 539–545, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. K. E. S. Poole, J. Reeve, and E. A. Warburton, “Falls, fractures, and osteoporosis after stroke: time to think about protection,” Stroke, vol. 33, no. 5, pp. 1432–1436, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. H. E. Whitson, C. F. Pieper, L. Sanders, R. D. Horner, P. W. Duncan, and K. W. Lyles, “Adding injury to insult: fracture risk after stroke in veterans,” Journal of the American Geriatrics Society, vol. 54, no. 7, pp. 1082–1088, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Yavuzer, S. Ataman, N. Suldur, et al., “Bone mineral density in patients with stroke,” International Journal of Rehabilitation Research, vol. 25, no. 3, pp. 235–239, 2002.
  27. M. S. Dennis, K. M. Lo, M. McDowall, and T. West, “Fractures after stroke: frequency, types, and associations,” Stroke, vol. 33, no. 3, pp. 728–734, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Kanis, A. Oden, and O. Johnell, “Acute and long-term increase in fracture risk after hospitalization for stroke,” Stroke, vol. 32, no. 3, pp. 702–706, 2001. View at Scopus
  29. A. Ramnemark, L. Nyberg, B. Borssén, T. Olsson, and Y. Gustafson, “Fractures after stroke,” Osteoporosis International, vol. 8, no. 1, pp. 92–95, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. D. L. Brown, L. B. Morgenstern, J. J. Majersik, M. Kleerekoper, and L. D. Lisabeth, “Risk of fractures after stroke,” Cerebrovascular Diseases, vol. 25, no. 1-2, pp. 95–99, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Fisher, W. Srikusalanukul, M. Davis, et al., “Cardiovascular diseases in older patients with osteoporotic hip fracture: prevalence, disturbances in mineral and bone metabolism, and bidirectional links,” Journal of Clinical Interventions in Aging, vol. 8, pp. 239–256, 2013.
  32. Y. Gerber, L. J. Melton III, S. M. McNallan, et al., “Cardiovascular and noncardiovascular disease associations with hip fractures,” The American Journal of Medicine, vol. 126, no. 2, pp. 169.e19–169.e26, 2013.
  33. P. Szulc, C. Maurice, F. Marchand, and P. D. Delmas, “Increased bone resorption is associated with higher mortality in community-dwelling men ≥50 years of age: the MINOS Study,” Journal of Bone and Mineral Research, vol. 24, no. 6, pp. 1116–1124, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. L. B. Tanko, C. Christiansen, D. A. Cox, M. J. Geiger, M. A. McNabb, and S. R. Cummings, “Relationship between osteoporosis and cardiovascular disease in postmenopausal women,” Journal of Bone and Mineral Research, vol. 20, no. 11, pp. 1912–1920, 2005. View at Scopus
  35. T. Youm, G. Aharonoff, J. D. Zuckerman, and K. J. Koval, “Effect of previous cerebrovascular accident on outcome after hip fracture,” Journal of Orthopaedic Trauma, vol. 14, no. 5, pp. 329–334, 2000. View at Scopus
  36. S. Pouwels, A. Lalmohamed, B. Leufkens et al., “Risk of hip/femur fracture after stroke: a population-based case-control study,” Stroke, vol. 40, no. 10, pp. 3281–3285, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. C.-H. Wu, T.-H. Liou, P.-L. Hsiao, Y.-C. Lin, and K.-H. Chang, “Contribution of ischemic stroke to hip fracture risk and the influence of gender difference,” Archives of Physical Medicine and Rehabilitation, vol. 92, no. 12, pp. 1987–1991, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. C. S. Colón-Emeric, C. F. Pieper, and M. B. Artz, “Can historical and functional risk factors be used to predict fractures in community-dwelling older adults? Development and validation of a clinical tool,” Osteoporosis International, vol. 13, no. 12, pp. 955–961, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. S. R. Cummings, M. C. Nevitt, W. S. Browner et al., “Risk factors for hip fracture in white women,” New England Journal of Medicine, vol. 332, no. 12, pp. 767–773, 1995. View at Publisher · View at Google Scholar · View at Scopus
  40. L. J. Melton III, R. D. Brown Jr., S. J. Achenbach, W. M. O'Fallon, and J. P. Whisnant, “Long-term fracture risk following ischemic stroke: a population-based Study,” Osteoporosis International, vol. 12, no. 11, pp. 980–986, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Y. Chiu, W. K. Pun, K. D. K. Luk, and S. P. Chow, “A prospective study on hip fractures in patients with previous cerebrovascular accidents,” Injury, vol. 23, no. 5, pp. 297–299, 1992. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Peszczynski, “The fractured hip in hemiplegic patients,” Geriatrics, vol. 12, no. 12, pp. 687–690, 1957. View at Scopus
  43. Z. P. Stavrou, D. A. Erginousakis, A. A. Loizides, S. A. Tzevelekos, and K. J. Papagiannakos, “Mortality and rehabilitation following hip fracture. A study of 202 elderly patients,” Acta Orthopaedica Scandinavica, Supplementum, vol. 68, no. 275, pp. 89–91, 1997. View at Scopus
  44. A. M. Kramer, J. F. Steiner, R. E. Schlenker et al., “Outcomes and costs after hip fracture and stroke: a comparison of rehabilitation settings,” Journal of the American Medical Association, vol. 277, no. 5, pp. 396–404, 1997. View at Scopus
  45. A.-R. Poplingher and T. Pillar, “Hip fracture in stroke patients. Epidemiology and rehabilitation,” Acta Orthopaedica Scandinavica, vol. 56, no. 3, pp. 226–227, 1985. View at Scopus
  46. A. Gaudio, P. Pennisi, C. Bratengeier et al., “Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 5, pp. 2248–2253, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. N. Paker, D. Bugdayci, D. Tekdos, C. Dere, and B. Kaya, “Relationship between bone turnover and bone density at the proximal femur in stroke patients,” Journal of Stroke and Cerebrovascular Diseases, vol. 18, no. 2, pp. 139–143, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. A. S. Levey, J. Coresh, T. Greene et al., “Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values,” Clinical Chemistry, vol. 53, no. 4, pp. 766–772, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. K. Kushida, M. Takahashi, K. Kawana, and T. Inoue, “Comparison of markers for bone formation and resorption in premenopausal and postmenopausal subjects, and osteoporosis patients,” Journal of Clinical Endocrinology and Metabolism, vol. 80, no. 8, pp. 2447–2450, 1995. View at Scopus
  50. M. Takahashi, K. Naitou, T. Ohishi, and A. Nagano, “Comparison of biochemical markers of bone turnover and bone mineral density between hip fracture and vertebral fracture,” Journal of Clinical Densitometry, vol. 6, no. 3, pp. 211–218, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. I. Elkhatib, W. Cao, S. Rao, J. Fryer, and A. L. Buchman, “Serum B12 concentration is elevated in patients receiving chronic parenteral nutrition, but is not a marker of intestinal failure-associated liver disease,” Journal of Clinical Gastroenterology, vol. 44, no. 8, pp. 571–574, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. A. A. M. Ermens, L. T. Vlasveld, and J. Lindemans, “Significance of elevated cobalamin (vitamin B12) levels in blood,” Clinical Biochemistry, vol. 36, no. 8, part 1, pp. 585–590, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. K. Serraj, M. Mecili, I. Housni, and E. Andrès, “Hypervitaminemia B12 (high level of cobalamin): physiopathology, role and interest in clinical practice,” Presse Médicale, vol. 40, no. 12, Part 1, pp. 1120–1127, 2011. View at Scopus
  54. I. Kanazawa, T. Yamaguchi, M. Yamamoto, M. Yamauchi, S. Yano, and T. Sugimoto, “Serum osteocalcin/bone-specific alkaline phosphatase ratio is a predictor for the presence of vertebral fractures in men with type 2 diabetes,” Calcified Tissue International, vol. 85, no. 3, pp. 228–234, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. G. Mulley and A. J. Espley, “Hip fracture after hemiplegia,” Postgraduate Medical Journal, vol. 55, no. 642, pp. 264–265, 1979. View at Scopus
  56. L. D. Lisabeth, L. B. Morgenstern, J. J. Wing, et al., “Poststroke fractures in a bi-ethnic community,” Journal of Stroke & Cerebrovascular Diseases, vol. 21, no. 6, pp. 471–477, 2012.
  57. R. A. Haast, D. R. Gustafson, and A. J. Kiliaan, “Sex differences in stroke,” Journal of Cerebral Blood Flow and Metabolism, vol. 32, no. 12, pp. 2100–2107, 2012.
  58. Y. Z. Bagger, L. B. Tankó, P. Alexandersen, G. Qin, and C. Christiansen, “Radiographic measure of aorta calcification is a site-specific predictor of bone loss and fracture risk at the hip,” Journal of Internal Medicine, vol. 259, no. 6, pp. 598–605, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. T. C. Collins, S. K. Ewing, S. J. Diem et al., “Peripheral arterial disease is associated with higher rates of hip bone loss and increased fracture risk in older men,” Circulation, vol. 119, no. 17, pp. 2305–2312, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. D. den Uyl, M. T. Nurmohamed, L. H. D. van Tuyl, H. G. Raterman, and W. F. Lems, “(Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; A systematic review of the association between cardiovascular disease and osteoporosis,” Arthritis Research and Therapy, vol. 13, no. 1, p. R5, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. A. E. Hak, H. A. P. Pols, A. M. Van Hemert, A. Hofman, and J. C. M. Witteman, “Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal Study,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 8, pp. 1926–1931, 2000. View at Scopus
  62. M. Naves, M. Rodriguez-Garcia, J. B. Diaz-Lopez, et al., “Progression of vascular calcifications is associated with greater bone loss and increased bone fractures,” Osteoporosis International, vol. 19, no. 8, pp. 1161–1166, 2008.
  63. U. Sennerby, H. Melhus, R. Gedeborg et al., “Cardiovascular diseases and risk of hip fracture,” Journal of the American Medical Association, vol. 302, no. 15, pp. 1666–1673, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. P. Szulc, D. P. Kiel, and P. D. Delmas, “Calcifications in the abdominal aorta predict fractures in men: MINOS Study,” Journal of Bone and Mineral Research, vol. 23, no. 1, pp. 95–102, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. D. Von Mühlen, M. Allison, S. K. Jassal, and E. Barrett-Connor, “Peripheral arterial disease and osteoporosis in older adults: the Rancho Bernardo Study,” Osteoporosis International, vol. 20, no. 12, pp. 2071–2078, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. J. B. J. Van Meurs, R. A. M. Dhonukshe-Rutten, S. M. F. Pluijm et al., “Homocysteine levels and the risk of osteoporotic fracture,” New England Journal of Medicine, vol. 350, no. 20, pp. 2033–2041, 2004. View at Publisher · View at Google Scholar · View at Scopus
  67. R. R. McLean, P. F. Jacques, J. Selhub et al., “Homocysteine as a predictive factor for hip fracture in older persons,” New England Journal of Medicine, vol. 350, no. 20, pp. 2042–2049, 2004. View at Publisher · View at Google Scholar · View at Scopus
  68. Y. Sato, Y. Honda, J. Iwamoto, T. Kanoko, and K. Satoh, “Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial,” Journal of the American Medical Association, vol. 293, no. 9, pp. 1082–1088, 2005. View at Publisher · View at Google Scholar · View at Scopus
  69. Y. Sato, M. Kaji, N. Metoki, K. Satoh, and J. Iwamoto, “Does compensatory hyperparathyroidism predispose to ischemic stroke?” Neurology, vol. 60, no. 4, pp. 626–629, 2003. View at Scopus
  70. R. A. M. Dhonukshe-Rutten, S. M. F. Pluijm, L. C. P. G. M. De Groot, P. Lips, J. H. Smit, and W. A. Van Staveren, “Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people,” Journal of Bone and Mineral Research, vol. 20, no. 6, pp. 921–929, 2005. View at Publisher · View at Google Scholar · View at Scopus
  71. J. Yang, X. Hu, Q. Zhang, et al., “Homocysteine level and risk of fracture: a meta-analysis and systematic review,” Bone, vol. 51, no. 3, pp. 376–382, 2012.
  72. P. Gerdhem, K. K. Ivaska, A. Isaksson et al., “Associations between homocysteine, bone turnover, BMD, mortality, and fracture risk in elderly women,” Journal of Bone and Mineral Research, vol. 22, no. 1, pp. 127–134, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. C. G. Gjesdal, S. E. Vollset, P. M. Ueland, H. Refsum, H. E. Meyer, and G. S. Tell, “Plasma homocysteine, folate, and vitamin B12 and the risk of hip fracture: the hordaland homocysteine study,” Journal of Bone and Mineral Research, vol. 22, no. 5, pp. 747–756, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. K. L. Stone, D. C. Bauer, D. Sellmeyer, and S. R. Cummings, “Low serum vitamin B-12 levels are associated with increased hip bone loss in older women: a prospective Study,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 3, pp. 1217–1221, 2004. View at Publisher · View at Google Scholar · View at Scopus
  75. K. L. Tucker, M. T. Hannan, N. Qiao et al., “Low plasma vitamin B12 is associated with lower BMD: the framingham osteoporosis Study,” Journal of Bone and Mineral Research, vol. 20, no. 1, pp. 152–158, 2005. View at Publisher · View at Google Scholar · View at Scopus
  76. K. L. Tucker, N. Qiao, T. Scott, I. Rosenberg, and A. Spiro III, “High homocysteine and low B vitamins predict cognitive decline in aging men: the veterans affairs normative aging Study,” American Journal of Clinical Nutrition, vol. 82, no. 3, pp. 627–635, 2005. View at Scopus
  77. M. Herrmann, B. Wildemann, A. Wagner et al., “Experimental folate and vitamin B12 deficiency does not alter bone quality in rats,” Journal of Bone and Mineral Research, vol. 24, no. 4, pp. 589–596, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. J. H. Holstein, M. Herrmann, C. Splett et al., “Hyperhomocysteinemia is not associated with reduced bone quality in humans with hip osteoarthritis,” Clinical Chemistry and Laboratory Medicine, vol. 48, no. 6, pp. 821–827, 2010. View at Publisher · View at Google Scholar · View at Scopus
  79. A. M. Kakehasi, A. V. Carvalho, F. A. Maksud, et al., “Serum levels of vitamin B12 are not related to low bone mineral density in postmenopausal Brazilian women,” Revista Brasileira de Reumatologia, vol. 52, no. 6, pp. 863–869, 2012.
  80. A. Cagnacci, B. Bagni, A. Zini, M. Cannoletta, M. Generali, and A. Volpe, “Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation,” Bone, vol. 42, no. 2, pp. 314–320, 2008. View at Publisher · View at Google Scholar · View at Scopus
  81. R. C. M. Ho, M. W. L. Cheung, E. Fu et al., “Is high homocysteine level a risk factor for cognitive decline in elderly? A systematic review, meta-analysis, and meta-regression,” American Journal of Geriatric Psychiatry, vol. 19, no. 7, pp. 607–617, 2011. View at Publisher · View at Google Scholar · View at Scopus
  82. F. Van Dam and W. A. Van Gool, “Hyperhomocysteinemia and Alzheimer's disease: a systematic review,” Archives of Gerontology and Geriatrics, vol. 48, no. 3, pp. 425–430, 2009. View at Publisher · View at Google Scholar · View at Scopus
  83. G. J. Hankey, J. W. Eikelboom, Q. Yi et al., “Treatment with B vitamins and incidence of cancer in patients with previous stroke or transient ischemic attack: results of a randomized placebo-controlled trial,” Stroke, vol. 43, pp. 1572–1577, 2012. View at Publisher · View at Google Scholar · View at Scopus
  84. C. M. Albert, N. R. Cook, J. M. Gaziano et al., “Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial,” Journal of the American Medical Association, vol. 299, no. 17, pp. 2027–2036, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. K. Potter, G. J. Hankey, D. J. Green, J. Eikelboom, K. Jamrozik, and L. F. Arnolda, “The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis,” BMC Cardiovascular Disorders, vol. 8, article 24, 2008. View at Publisher · View at Google Scholar · View at Scopus
  86. J. F. Toole, M. R. Malinow, L. E. Chambless et al., “Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial,” Journal of the American Medical Association, vol. 291, no. 5, pp. 565–575, 2004. View at Publisher · View at Google Scholar · View at Scopus
  87. A. Grossfeld, S. Dekel, Y. Lerman, et al., “Symptomatic venous thromboembolism in elderly patients following major orthopedic surgery of the lower limb is associated with elevated vitamin B12 serum levels,” Clinical Biochemistry, vol. 46, no. 1-2, pp. 54–58, 2013.
  88. P. Geissbühler, B. Mermillod, and C.-H. Rapin, “Elevated serum vitamin B12 levels associated with CRP as a predictive factor of mortality in palliative care cancer patients: a prospective study over five years,” Journal of Pain and Symptom Management, vol. 20, no. 2, pp. 93–103, 2000. View at Publisher · View at Google Scholar · View at Scopus
  89. S. Sviri, R. Khalaila, S. Daher et al., “Increased Vitamin B12 levels are associated with mortality in critically ill medical patients,” Clinical Nutrition, vol. 31, no. 1, pp. 53–59, 2012. View at Publisher · View at Google Scholar · View at Scopus
  90. S. Tal, Y. Shavit, F. Stern, and S. Malnick, “Association between vitamin B12 levels and mortality in hospitalized older adults,” Journal of the American Geriatrics Society, vol. 58, no. 3, pp. 523–526, 2010. View at Publisher · View at Google Scholar · View at Scopus
  91. A. A. House, M. Eliasziw, D. C. Cattran et al., “Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial,” Journal of the American Medical Association, vol. 303, no. 16, pp. 1603–1609, 2010. View at Publisher · View at Google Scholar · View at Scopus
  92. M. Ebbing, K. H. Bønaa, O. Nygård et al., “Cancer incidence and mortality after treatment with folic acid and vitamin B12,” Journal of the American Medical Association, vol. 302, no. 19, pp. 2119–2126, 2009. View at Publisher · View at Google Scholar · View at Scopus
  93. Y. Fujimatsu, “Role of the parathyroid gland on bone mass and metabolism in immobilized stroke patients,” Kurume Medical Journal, vol. 45, no. 3, pp. 265–270, 1998. View at Scopus
  94. Q. Sun, A. Pan, F. B. Hu, J. E. Manson, and K. M. Rexrode, “25-hydroxyvitamin D levels and the risk of stroke: a prospective Study and meta-analysis,” Stroke, vol. 43, pp. 1470–1477, 2012. View at Publisher · View at Google Scholar · View at Scopus
  95. Y. Sato, T. Asoh, I. Kondo, and K. Satoh, “Vitamin D deficiency and risk of hip fractures among disabled elderly stroke patients,” Stroke, vol. 32, no. 7, pp. 1673–1677, 2001. View at Scopus
  96. Y. Sato, J. Iwamoto, and Y. Honda, “Beneficial effect of etidronate therapy in chronically hospitalized, disabled patients with stroke,” Journal of Stroke and Cerebrovascular Diseases, vol. 19, no. 3, pp. 198–203, 2010. View at Publisher · View at Google Scholar · View at Scopus
  97. Y. Sato, J. Iwamoto, and Y. Honda, “An open-label trial comparing alendronate and alphacalcidol in reducing falls and hip fractures in disabled stroke patients,” Journal of Stroke and Cerebrovascular Diseases, vol. 20, no. 1, pp. 41–46, 2011. View at Publisher · View at Google Scholar · View at Scopus
  98. D. K. Dhanwal, S. Sahoo, V. K. Gautam, and R. Saha, “Hip fracture patients in India have vitamin D deficiency and secondary hyperparathyroidism,” Osteoporosis International, vol. 24, pp. 553–557, 2012. View at Publisher · View at Google Scholar · View at Scopus
  99. M. Di Monaco, C. Castiglioni, F. Vallero, et al., “Parathyroid hormone response to severe vitamin D deficiency is sex associated: an observational study of 571 hip fracture inpatients,” Journal of Nutrition Health and Aging, vol. 17, no. 2, pp. 180–184, 2013.
  100. P. Lips, “Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications,” Endocrine Reviews, vol. 22, no. 4, pp. 477–501, 2001. View at Publisher · View at Google Scholar · View at Scopus
  101. C. Bosworth, M. C. Sachs, D. Duprez, et al., “Parathyroid hormone and arterial dysfunction in the Multi-Ethnic Study of Atherosclerosis,” Clinical Endocrinology, vol. 79, no. 3, pp. 429–436, 2013.
  102. I. H. De Boer, B. Kestenbaum, A. B. Shoben, E. D. Michos, M. J. Sarnak, and D. S. Siscovick, “25-Hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification,” Journal of the American Society of Nephrology, vol. 20, no. 8, pp. 1805–1812, 2009. View at Publisher · View at Google Scholar · View at Scopus
  103. A. J. van Ballegooijen, M. Visser, B. Kestenbaum, et al., “Relation of vitamin D and parathyroid hormone to cardiac biomarkers and to left ventricular mass (from the cardiovascular dealth Study),” American Journal of Cardiology, vol. 111, no. 3, pp. 418–424, 2013.
  104. G. Zhao, E. S. Ford, C. Li, P. M. Kris-Etherton, T. D. Etherton, and L. S. Balluz, “Independent associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with blood pressure among US adults,” Journal of Hypertension, vol. 28, no. 9, pp. 1821–1828, 2010. View at Publisher · View at Google Scholar · View at Scopus
  105. K. K. Andersen and T. S. Olsen, “One-month to 10-year survival in the copenhagen stroke Study: interactions between stroke severity and other prognostic indicators,” Journal of Stroke and Cerebrovascular Diseases, vol. 20, no. 2, pp. 117–123, 2011. View at Publisher · View at Google Scholar · View at Scopus
  106. C. Bosworth and I. H. de Boer, “Impaired vitamin D metabolism in CKD,” Seminars in Nephrology, vol. 33, no. 2, pp. 158–168, 2013.
  107. B. Kestenbaum, R. Katz, I. De Boer et al., “Vitamin D, parathyroid hormone, and cardiovascular events among older adults,” Journal of the American College of Cardiology, vol. 58, no. 14, pp. 1433–1441, 2011. View at Publisher · View at Google Scholar · View at Scopus
  108. B. Schottker, U. Haug, L. Schomburg, et al., “Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large Cohort Study,” American Journal of Clinical Nutrition, vol. 97, no. 4, pp. 782–793, 2013.
  109. T. Sugimoto, K. Dohi, K. Onishi, et al., “Interrelationship between haemodynamic state and serum intact parathyroid hormone levels in patients with chronic heart failure,” Heart, vol. 99, no. 2, pp. 111–115, 2013.
  110. J. Terrovitis, P. Zotos, E. Kaldara et al., “Bone mass loss in chronic heart failure is associated with secondary hyperparathyroidism and has prognostic significance,” European Journal of Heart Failure, vol. 14, no. 3, pp. 326–332, 2012. View at Publisher · View at Google Scholar · View at Scopus
  111. L. Wang, Y. Song, J. E. Manson, et al., “Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies,” Cardiovascular Quality and Outcomes, vol. 5, no. 6, pp. 819–829, 2012.
  112. P. Brondum-Jacobsen, B. G. Nordestgaard, P. Schnohr, et al., “25-Hydroxyvitamin D and symptomatic ischemic stroke: an original Study and meta-analysis,” Annals of Neurology, vol. 73, no. 1, pp. 38–47, 2013.
  113. E. Giovannucci, “Vitamin D and cardiovascular disease,” Current Atherosclerosis, vol. 11, no. 6, pp. 456–461, 2009.
  114. R. Jorde, J. Sundsfjord, E. Haug, and K. H. Bønaa, “Relation between low calcium intake, parathyroid hormone, and blood pressure,” Hypertension, vol. 35, no. 5, pp. 1154–1159, 2000. View at Scopus
  115. R. Jorde, J. Svartberg, and J. Sundsfjord, “Serum parathyroid hormone as a predictor of increase in systolic blood pressure in men,” Journal of Hypertension, vol. 23, no. 9, pp. 1639–1644, 2005. View at Scopus
  116. A. Jungert, H. J. Roth, and M. Neuhauser-Berthold, “Serum 25-hydroxyvitamin D3, parathyroid hormone and blood pressure in an elderly cohort from Germany: a cross-sectional Study,” Nutrition & Metabolism, vol. 9, article 20, 2012. View at Publisher · View at Google Scholar · View at Scopus
  117. K. Li, R. Kaaks, J. Linseisen, et al., “Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and nutrition Study (EPIC-Heidelberg),” Heart, vol. 98, no. 12, pp. 920–925, 2012.
  118. L. Li, X. Yin, C. Yao, et al., “Vitamin D, parathyroid hormone and their associations with hypertension in a Chinese population,” Plos One, vol. 7, no. 8, Article ID e43344, 2012. View at Publisher · View at Google Scholar
  119. S. Pilz, H. Dobnig, J. E. Fischer et al., “Low vitamin D levels predict stroke in patients referred to coronary angiography,” Stroke, vol. 39, no. 9, pp. 2611–2613, 2008. View at Publisher · View at Google Scholar · View at Scopus
  120. J. P. Reis, D. Von Mühlen, D. Kritz-Silverstein, D. L. Wingard, and E. Barrett-Connor, “Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults,” Diabetes Care, vol. 30, no. 6, pp. 1549–1555, 2007. View at Publisher · View at Google Scholar · View at Scopus
  121. E. N. Taylor, G. C. Curhan, and J. P. Forman, “Parathyroid hormone and the risk of incident hypertension,” Journal of Hypertension, vol. 26, no. 7, pp. 1390–1394, 2008. View at Publisher · View at Google Scholar · View at Scopus
  122. T. J. Wang, M. J. Pencina, S. L. Booth et al., “Vitamin D deficiency and risk of cardiovascular disease,” Circulation, vol. 117, no. 4, pp. 503–511, 2008. View at Publisher · View at Google Scholar · View at Scopus
  123. R. Chan, D. Chan, J. Woo et al., “Serum 25-hydroxyvitamin D and parathyroid hormone levels in relation to blood pressure in a cross-sectional study in older Chinese men,” Journal of Human Hypertension, vol. 26, no. 1, pp. 20–27, 2012. View at Publisher · View at Google Scholar · View at Scopus
  124. M. B. Snijder, P. Lips, J. C. Seidell et al., “Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women,” Journal of Internal Medicine, vol. 261, no. 6, pp. 558–565, 2007. View at Publisher · View at Google Scholar · View at Scopus
  125. E. Kamycheva, J. Sundsfjord, and R. Jorde, “Serum parathyroid hormone levels predict coronary heart disease: the Tromsø Study,” European Journal of Cardiovascular Prevention and Rehabilitation, vol. 11, no. 1, pp. 69–74, 2004. View at Publisher · View at Google Scholar · View at Scopus
  126. H. S. Choi, S. H. Kim, Y. Rhee, M. A. Cho, E. J. Lee, and S.-K. Lim, “Serum parathyroid hormone is associated with carotid intima-media thickness in postmenopausal women,” International Journal of Clinical Practice, vol. 62, no. 9, pp. 1352–1357, 2008. View at Publisher · View at Google Scholar · View at Scopus
  127. M. D. Walker, J. Fleischer, T. Rundek et al., “Carotid vascular abnormalities in primary hyperparathyroidism,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 10, pp. 3849–3856, 2009. View at Publisher · View at Google Scholar · View at Scopus
  128. A. Saverino, M. Del Sette, M. Conti et al., “Hyperechoic plaque: an ultrasound marker for osteoporosis in acute stroke patients with carotid disease,” European Neurology, vol. 55, no. 1, pp. 31–36, 2006. View at Publisher · View at Google Scholar · View at Scopus
  129. Y. Sato, “Abnormal bone and calcium metabolism in patients after stroke,” Archives of Physical Medicine and Rehabilitation, vol. 81, no. 1, pp. 117–121, 2000.
  130. N. J. Bainbridge, M. W. J. Davie, and M. J. Haddaway, “Bone loss after stroke over 52 weeks at os calcis: influence of sex, mobility and relation to bone density at other sites,” Age and Ageing, vol. 35, no. 2, pp. 127–132, 2006. View at Publisher · View at Google Scholar · View at Scopus
  131. M. J. Bolland, C. J. Bacon, A. M. Horne et al., “Vitamin D insufficiency and health outcomes over 5 y in older women,” American Journal of Clinical Nutrition, vol. 91, no. 1, pp. 82–89, 2010. View at Publisher · View at Google Scholar · View at Scopus
  132. C. Drechsler, S. Pilz, B. Obermayer-Pietsch et al., “Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients,” European Heart Journal, vol. 31, no. 18, pp. 2253–2261, 2010. View at Publisher · View at Google Scholar · View at Scopus
  133. J. P. Forman, G. C. Curhan, and E. N. Taylor, “Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women,” Hypertension, vol. 52, no. 5, pp. 828–832, 2008. View at Publisher · View at Google Scholar · View at Scopus
  134. J. P. Reis, D. von Mühlen, E. D. Michos et al., “Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis,” Atherosclerosis, vol. 207, no. 2, pp. 585–590, 2009. View at Publisher · View at Google Scholar · View at Scopus
  135. P. Lips, “Vitamin D physiology,” Progress in Biophysics & Molecular Biology, vol. 92, no. 1, pp. 4–8, 2006.
  136. J. J. Wysolmerski, “Parathyroid hormone-related protein: an update,” Journal of Clinical Endocrinology & Metabolism, vol. 97, no. 9, pp. 2947–2956, 2012.
  137. E. Hagström, P. Hellman, T. E. Larsson et al., “Plasma parathyroid hormone and the risk of cardiovascular mortality in the community,” Circulation, vol. 119, no. 21, pp. 2765–2771, 2009. View at Publisher · View at Google Scholar · View at Scopus
  138. L. L. Schierbeck, T. S. Jensen, U. Bang, G. Jensen, L. Køber, and J.-E. B. Jensen, “Parathyroid hormone and vitamin D—markers for cardiovascular and all cause mortality in heart failure,” European Journal of Heart Failure, vol. 13, no. 6, pp. 626–632, 2011. View at Publisher · View at Google Scholar · View at Scopus
  139. J. L. Anderson, R. C. Vanwoerkom, B. D. Horne et al., “Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?” American Heart Journal, vol. 162, no. 2, pp. 331.e2–339.e2, 2011. View at Publisher · View at Google Scholar · View at Scopus
  140. S. Pilz and A. Tomaschitz, “Role of vitamin D in arterial hypertension,” Expert Review of Cardiovascular Therapy, vol. 8, no. 11, pp. 1599–1608, 2010. View at Publisher · View at Google Scholar · View at Scopus
  141. I. Tastan, R. Schreckenberg, S. Mufti, Y. Abdallah, H. M. Piper, and K.-D. Schlüter, “Parathyroid hormone improves contractile performance of adult rat ventricular cardiomyocytes at low concentrations in a non-acute way,” Cardiovascular Research, vol. 82, no. 1, pp. 77–83, 2009. View at Publisher · View at Google Scholar · View at Scopus
  142. B. Jiang, S. Morimoto, J. Yang, T. Niinoabu, K. Fukuo, and T. Ogihara, “Expression of parathyroid hormone/parathyroid hormone-related protein receptor in vascular endothelial cells,” Journal of Cardiovascular Pharmacology, vol. 31, supplement 1, pp. S142–S144, 1998. View at Scopus
  143. G. Rashid, J. Bernheim, J. Green, and S. Benchetrit, “Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways,” American Journal of Physiology. Renal Physiology, vol. 292, no. 4, pp. F1215–F1218, 2007. View at Publisher · View at Google Scholar · View at Scopus
  144. N. C. Grandi, L. P. Breitling, and H. Brenner, “Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies,” Preventive Medicine, vol. 51, no. 3-4, pp. 228–233, 2010. View at Publisher · View at Google Scholar · View at Scopus
  145. M. Björkman, A. Sorva, and R. Tilvis, “Parathyroid hormone as a mortality predictor in frail aged inpatients,” Gerontology, vol. 55, no. 6, pp. 601–606, 2009. View at Publisher · View at Google Scholar · View at Scopus
  146. C. Lin, X. Jiang, Z. Dai et al., “Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/β-catenin signaling,” Journal of Bone and Mineral Research, vol. 24, no. 10, pp. 1651–1661, 2009. View at Publisher · View at Google Scholar · View at Scopus
  147. A. Fahrleitner-Pammer, J. Herberth, S. R. Browning et al., “Bone markers predict cardiovascular events in chronic kidney disease,” Journal of Bone and Mineral Research, vol. 23, no. 11, pp. 1850–1858, 2008. View at Publisher · View at Google Scholar · View at Scopus
  148. P. Manghat, I. Souleimanova, J. Cheung et al., “Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD),” Bone, vol. 48, no. 5, pp. 1127–1132, 2011. View at Publisher · View at Google Scholar · View at Scopus
  149. C. Tomiyama, A. B. Carvalho, A. Higa, V. Jorgetti, S. A. Draibe, and M. E. F. Canziani, “Coronary calcification is associated with lower bone formation rate in CKD patients not yet in dialysis treatment,” Journal of Bone and Mineral Research, vol. 25, no. 3, pp. 499–504, 2010. View at Publisher · View at Google Scholar · View at Scopus
  150. G. S. Stein and J. B. Lian, “Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype,” Endocrine Reviews, vol. 14, no. 4, pp. 424–442, 1993. View at Publisher · View at Google Scholar · View at Scopus
  151. G. S. Kim, C.-H. Kim, J. Y. Park, K.-U. Lee, and C. S. Park, “Effects of vitamin B12 on cell proliferation and cellular alkaline phosphatase activity in human bone marrow stromal osteoprogenitor cells and UMR106 osteoblastic cells,” Metabolism, vol. 45, no. 12, pp. 1443–1446, 1996. View at Publisher · View at Google Scholar · View at Scopus
  152. B. L. T. Vaes, C. Lute, H. J. Blom et al., “Vitamin B12 deficiency stimulates osteoclastogenesis via increased homocysteine and methylmalonic acid,” Calcified Tissue International, vol. 84, no. 5, pp. 413–422, 2009. View at Publisher · View at Google Scholar · View at Scopus
  153. M. Herrmann, J. Peter Schmidt, N. Umanskaya et al., “The role of hyperhomocysteinemia as well as folate, vitamin B6 and B12 deficiencies in osteoporosis: a systematic review,” Clinical Chemistry and Laboratory Medicine, vol. 45, no. 12, pp. 1621–1632, 2007. View at Publisher · View at Google Scholar · View at Scopus
  154. J. H. Ix, I. H. De Boer, C. A. Peralta et al., “Serum phosphorus concentrations and arterial stiffness among individuals with normal kidney function to moderate kidney disease in MESA,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 3, pp. 609–615, 2009. View at Publisher · View at Google Scholar · View at Scopus
  155. R. Dhingra, L. M. Sullivan, C. S. Fox et al., “Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community,” Archives of Internal Medicine, vol. 167, no. 9, pp. 879–885, 2007. View at Publisher · View at Google Scholar · View at Scopus
  156. J. R. Dominguez, B. Kestenbaum, M. Chonchol, et al., “Relationships between serum and urine phosphorus with all-cause and cardiovascular mortality: the osteoporotic fractures in men (MrOS) Study,” American Journal of Kidney Diseases, vol. 61, no. 4, pp. 555–563, 2013.
  157. M. Nakayama, Y. Kaizu, M. Nagata, et al., “Fibroblast growth factor 23 is associated with carotid artery calcification in chronic kidney disease patients not undergoing dialysis: a cross-sectional study,” BMC Nephrology, vol. 14, article 22, 2013.
  158. S. J. Onufrak, A. Bellasi, L. J. Shaw et al., “Phosphorus levels are associated with subclinical atherosclerosis in the general population,” Atherosclerosis, vol. 199, no. 2, pp. 424–431, 2008. View at Publisher · View at Google Scholar · View at Scopus
  159. A. A. Fisher, W. Srikusalanukul, M. W. Davis, et al., “Clinical profiles and risk factors for outcomes in older patients with cervical and trochanteric hip fracture: similarities and differences,” Journal of Trauma Management & Outcomes, vol. 6, no. 1, p. 2, 2012.
  160. N. K. Lee and G. Karsenty, “Reciprocal regulation of bone and energy metabolism,” Trends in Endocrinology and Metabolism, vol. 19, no. 5, pp. 161–166, 2008. View at Publisher · View at Google Scholar · View at Scopus
  161. M. H. De Borst, M. G. Vervloet, P. M. Ter Wee, and G. Navis, “Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease,” Journal of the American Society of Nephrology, vol. 22, no. 9, pp. 1603–1609, 2011. View at Publisher · View at Google Scholar · View at Scopus
  162. S.-Z. Liu, L.-F. Tian, P. Xu et al., “Analysis of correlation between blood biochemical indicators and bone mineral density of post-menopausal women,” Molecular Biology Reports, vol. 38, no. 2, pp. 939–948, 2011. View at Publisher · View at Google Scholar · View at Scopus
  163. O. Gutierrez, T. Isakova, E. Rhee et al., “Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease,” Journal of the American Society of Nephrology, vol. 16, no. 7, pp. 2205–2215, 2005. View at Publisher · View at Google Scholar · View at Scopus
  164. L. Desjardins, S. Liabeuf, C. Renard et al., “FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages,” Osteoporosis International, vol. 23, no. 7, pp. 2017–2025, 2011. View at Publisher · View at Google Scholar · View at Scopus
  165. M. A. I. Mirza, A. Larsson, L. Lind, and T. E. Larsson, “Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community,” Atherosclerosis, vol. 205, no. 2, pp. 385–390, 2009. View at Publisher · View at Google Scholar · View at Scopus
  166. J. Bernheim and S. Benchetrit, “The potential roles of FGF23 and klotho in the prognosis of renal and cardiovascular diseases,” Nephrology Dialysis Transplantation, vol. 26, no. 8, pp. 2433–2438, 2011. View at Publisher · View at Google Scholar · View at Scopus
  167. J. H. Ix, R. Katz, B. R. Kestenbaum, et al., “Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS, (Cardiovascular Health Study),” Journal of the American College of Cardiology, vol. 60, no. 3, pp. 200–207, 2012.
  168. T. Isakova, P. Wahl, G. S. Vargas et al., “Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease,” Kidney International, vol. 79, no. 12, pp. 1370–1378, 2011. View at Publisher · View at Google Scholar · View at Scopus
  169. M. A. I. Mirza, M. K. Karlsson, D. Mellström et al., “Serum fibroblast growth factor-23 (FGF-23) and fracture risk in elderly men,” Journal of Bone and Mineral Research, vol. 26, no. 4, pp. 857–864, 2011. View at Publisher · View at Google Scholar · View at Scopus
  170. M. Roos, J. Lutz, H. Salmhofer et al., “Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function,” Clinical Endocrinology, vol. 68, no. 4, pp. 660–665, 2008. View at Publisher · View at Google Scholar · View at Scopus
  171. J. J. Scialla, W. L. Lau, M. P. Reilly, et al., “Fibroblast growth factor 23 is not associated with and does not induce arterial calcification,” Kidney International, vol. 83, no. 6, pp. 1159–1168, 2013.
  172. M. Di Monaco, F. Vallero, R. Di Monaco, F. Mautino, and A. Cavanna, “Functional recovery and length of stay after hip fracture in patients with neurologic impairment,” American Journal of Physical Medicine and Rehabilitation, vol. 82, no. 2, pp. 143–148, 2003. View at Publisher · View at Google Scholar · View at Scopus
  173. Y. Sato, J. Iwamoto, T. Kanoko, and K. Satoh, “Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial,” Cerebrovascular Diseases, vol. 20, no. 3, pp. 187–192, 2005. View at Publisher · View at Google Scholar · View at Scopus
  174. Y. Sato, J. Iwamoto, T. Kanoko, and K. Satoh, “Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke,” Archives of Internal Medicine, vol. 165, no. 15, pp. 1743–1748, 2005. View at Publisher · View at Google Scholar · View at Scopus
  175. K. E. S. Poole, N. Loveridge, P. J. Barker et al., “Reduced vitamin D in acute stroke,” Stroke, vol. 37, no. 1, pp. 243–245, 2006. View at Publisher · View at Google Scholar · View at Scopus
  176. M. E. Chung, J. I. Lee, S. Im, and J. H. Park, “Ischemic stroke in rats enhances bone resorption in vitro,” Journal of Korean Medical Science, vol. 27, no. 1, pp. 84–88, 2012. View at Publisher · View at Google Scholar · View at Scopus
  177. J. Iwamoto, T. Takeda, and H. Matsumoto, “Sunlight exposure is important for preventing hip fractures in patients with Alzheimer's disease, Parkinson's disease, or stroke,” Acta Neurologica Scandinavica, vol. 125, no. 4, pp. 279–284, 2012. View at Publisher · View at Google Scholar · View at Scopus
  178. F. Batchelor, K. Hill, S. MacKintosh, and C. Said, “What works in falls prevention after stroke?: a systematic review and meta-analysis,” Stroke, vol. 41, no. 8, pp. 1715–1722, 2010. View at Publisher · View at Google Scholar · View at Scopus
  179. F. A. Batchelor, S. F. Mackintosh, C. M. Said, et al., “Falls after stroke,” International Journal of Stroke, vol. 7, no. 6, pp. 482–490, 2012.
  180. K. Borschmann, “Exercise protects bone after stroke, or does it? A narrative review of the evidence,” Stroke Research and Treatment, vol. 2012, Article ID 103697, 12 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  181. K. Borschmann, M. Y. Pang, J. Bernhardt, et al., “Stepping towards prevention of bone loss after stroke: a systematic review of the skeletal effects of physical activity after stroke,” International Journal of Stroke, vol. 7, no. 4, pp. 330–335, 2012.
  182. N. M. Van Schoor, J. H. Smit, J. W. R. Twisk, L. M. Bouter, and P. Lips, “Prevention of hip fractures by external hip protectors: a randomized controlled trial,” Journal of the American Medical Association, vol. 289, no. 15, pp. 1957–1962, 2003. View at Publisher · View at Google Scholar · View at Scopus
  183. M. Runge and G. Hunger, “Determinants of musculoskeletal frailty and the risk of falls in old age,” Journal of Musculoskeletal Neuronal Interactions, vol. 6, no. 2, pp. 167–173, 2006. View at Scopus
  184. A. G. Turner, F. Tjahyono, W. S. M. Chiu et al., “The role of the calcitonin receptor in protecting against induced hypercalcemia is mediated via its actions in osteoclasts to inhibit bone resorption,” Bone, vol. 48, no. 2, pp. 354–361, 2011. View at Publisher · View at Google Scholar · View at Scopus
  185. J.-J. Body, P. Bergmann, S. Boonen et al., “Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications,” Osteoporosis International, vol. 23, no. 1, supplement, pp. 1–23, 2012. View at Publisher · View at Google Scholar · View at Scopus
  186. P. Vestergaard, “Acute myocardial infarction and atherosclerosis of the coronary arteries in patients treated with drugs against osteoporosis: calcium in the vessels and not the bones?” Calcified Tissue International, vol. 90, no. 1, pp. 22–29, 2012. View at Publisher · View at Google Scholar · View at Scopus
  187. R. Rizzoli and J.-Y. Reginster, “Adverse drug reactions to osteoporosis treatments,” Expert Review of Clinical Pharmacology, vol. 4, no. 5, pp. 593–604, 2011. View at Publisher · View at Google Scholar · View at Scopus
  188. A. Vogiatzoglou, A. Oulhaj, A. D. Smith et al., “Determinants of plasma methylmalonic acid in a large population: implications for assessment of vitamin B12 status,” Clinical Chemistry, vol. 55, no. 12, pp. 2198–2206, 2009. View at Publisher · View at Google Scholar · View at Scopus